Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sex Med ; 11(2): qfac022, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-36970583

RESUMO

Background: Peyronie's disease has an impact on men's mental and physical health. Aim: We sought to translate the Peyronie's Disease Questionnaire into Danish, adapt it to the Danish cultural setting, and test it in a Danish population. Methods: Translation of the Peyronie's Disease Questionnaire was performed according to the guidelines for adapting health status measures for use in languages other than the source language by Beaton et al. The validated American Peyronie's Disease Questionnaire was developed to monitor patient symptoms after an intervention and to inspire a subsequent dialogue about physical and psychological symptoms with a healthcare provider, thereby allowing the patient and the healthcare professional to choose the best treatment. The expert committee agreed on a Danish version after cross-cultural adaptation. The Danish Peyronie's Disease Questionnaire was sent by electronic mail to a preselected group of 41 men with Peyronie's disease. Outcomes: After completing the questionnaire, 32 men participated in a video interview regarding the questionnaire and were asked to identify any problematic fields or areas open to misunderstanding. Results: The Peyronie's Disease Questionnaire underwent major modifications in light of the comments of the first 10 respondents. Thereafter, only minor changes were made until data saturation was reached after 27 of the 32 respondents had been interviewed. In 87% of respondents Peyronie's disease bothered from the last time they had intercourse, and 93% of the men experienced being bothered by having intercourse less often. Peyronie's disease made 73% of respondents feel bodily discomfort, and 88% had intercourse less often than they used to have due to Peyronie's disease. Clinical Implications: The Peyronie's Disease Questionnaire is a valuable tool in the crucial task of addressing Peyronie's disease, providing insight into the mental and sexual health problems as well as physical challenges faced by patients. Strengths and Limitations: The interviewer's modest experience in conducting interviews is believed to have been duly compensated for by continuous and accumulating learning-while-doing process because the same interviewer conducted all of the interviews and did so consecutively. Conclusions: Danish men expressed satisfaction with the questionnaire and found it valuable as a tool when visiting the doctor for the first time.

2.
Scand J Urol Nephrol ; 39(2): 143-7, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16032779

RESUMO

OBJECTIVE: To determine whether intravesical hyaluronic acid id effective in reducing the urinary frequency and pain associated with interstitial cystitis/painful bladder syndrome (IC/PBS). MATERIAL AND METHODS: In a prospective, unblinded, uncontrolled pilot study, 20 patients (age range 34-80 years), all suffering from IC/PBS, received weekly bladder instillations of hyaluronic acid for 1 month and monthly instillations for a further 2 months. Patients were then offered further monthly instillations and all were subsequently evaluated after 3 years. Patient outcomes assessed were urinary frequency, use of analgesics and pain. RESULTS: All patients completed the 3 months of hyaluronic acid treatment with mean decreases in nocturia and pain of 40% and 30%, respectively, and decrease in analgesic use. Thirteen patients (65%) responded to treatment (responders) and continued therapy, while seven patents withdrew, six because of a lack of response and one due to cystectomy. In the 13 patients who continued hyaluronic acid instillations, four complete responders(30%) ceased therapy after a strong positive response (36%, 60% and 81% decreases compared to baseline in day-time voids, night-time voids and scores, respectively) which was maintained in the absence of continuous therapy, while after 3 years seven partial responders (35%) were still on therapy (25% and 43% decreases compared to baseline in day-time voids and pain scores, respectively). Two patients developed other diseases during follow-up and showed no response to long-term therapy. Hyaluronic acid was will tolerated by all patients. CONCLUSION: Hyaluronic acid safely reduced the pain and, to lesser degree, the urinary frequency associated with IC.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Cistite Intersticial/tratamento farmacológico , Ácido Hialurônico/uso terapêutico , Adjuvantes Imunológicos/administração & dosagem , Administração Intravesical , Adulto , Idoso , Idoso de 80 Anos ou mais , Cistite Intersticial/complicações , Cistite Intersticial/patologia , Esquema de Medicação , Feminino , Seguimentos , Humanos , Ácido Hialurônico/administração & dosagem , Instilação de Medicamentos , Mastócitos/patologia , Pessoa de Meia-Idade , Dor/tratamento farmacológico , Dor/etiologia , Medição da Dor , Projetos Piloto , Estudos Prospectivos , Resultado do Tratamento , Transtornos Urinários/tratamento farmacológico , Transtornos Urinários/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...